Clinical Trial Update: Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides

View source ↗

Summary

A completed Special Drug Use Surveillance trial evaluated alogliptin in combination with biguanides for type 2 diabetes mellitus. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Surveillance | Status: COMPLETED | Results posted: 2017-04-13